NEWAMSTERDAM PHARMA COMPANY
NAMS·N62509109·US·Common Stock·Healthcare - Biotechnology-Activist
NAMS (NEWAMSTERDAM PHARMA COMPANY) is held by 112 institutional investors as of Q2 2026. Largest holders: Capital World Investors ($414.5M), FMR LLC ($350.4M), RA CAPITAL MANAGEMENT, L.P. ($323.7M). Net institutional sentiment: Mixed.
112
Holders
(10 Elite)
$2.6B
Total Value
66% (109)
Consensus
72 buying - 37 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 14, 2026 · Insiders Oct 2, 2026 · Activists Sep 22, 2026 · Congress none
InsiderKPKastelein Johannes Jacob PieterSell $1.3MSep 30, 2026
InsiderKPKastelein Johannes Jacob PieterExercise 50K shSep 30, 2026
ActivistFLFrazier Life Sciences X, L.P.6.1%Sep 22, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 118
1 / 6
Continue exploring
Other Healthcare stocks held by institutions
417 holders · $300.5B
416 holders · $881.6B
401 holders · $151.5B
398 holders · $415.6B
395 holders · $98.9B
394 holders · $111.8B
391 holders · $230.3B
386 holders · $303.9B
386 holders · $52.4B
383 holders · $114.2B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer